Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain

NCT02447848 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Acute Pain

Interventions

DRUG: sufentanil sublingual 30 mcg tablet

Sponsor

Talphera, Inc

Collaborators

[object Object]